Consolidated Statements of Equity - USD ($)	Total	Cumulative Effect, Period of Adoption, Adjustment	Preferred Stock	Common Stock	Additional Paid-In Capital	Additional Paid-In Capital Cumulative Effect, Period of Adoption, Adjustment	Treasury Stock	Retained Earnings / (Accumulated Deficit)	Retained Earnings / (Accumulated Deficit) Cumulative Effect, Period of Adoption, Adjustment
Beginning balance at Dec. 31, 2019	$ 11,210,000
Increase (Decrease) in Temporary Equity [Roll Forward]
Accretion adjustments of redeemable noncontrolling interest to redemption value	674,000
Net income / (loss) attributable to common stockholders	(1,193,000)
Ending balance at Dec. 31, 2020	10,691,000
Balance (in shares) at Dec. 31, 2019			0
Balance at Dec. 31, 2019	355,651,000	$ (816,000)	$ 0	$ 487,000	$ 365,627,000		$ 0	$ (10,463,000)	$ (816,000)
Balance (in shares) at Dec. 31, 2019				48,701,000
Balance (in shares) at Dec. 31, 2019							0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued in connection with equity based plans (in shares)				930,000
Common stock issued in connection with equity-based plans	$ 11,711,000			$ 9,000	11,702,000
Purchases of treasury stock (in shares)	147,153						147,000
Purchases of treasury stock	$ (5,149,000)						$ (5,149,000)
Stock-based compensation expense	29,176,000				29,176,000
Accretion adjustments of redeemable noncontrolling interest to redemption value	(674,000)				(674,000)
Net income / (loss) attributable to common stockholders	77,853,000							77,853,000
Balance (in shares) at Dec. 31, 2020			0
Balance at Dec. 31, 2020	$ 467,752,000		$ 0	$ 496,000	405,831,000		$ (5,149,000)	66,574,000
Balance (in shares) at Dec. 31, 2020				49,631,000
Balance (in shares) at Dec. 31, 2020							147,000
Accounting Standards Update [Extensible List]	Accounting Standards Update 2020-06 [Member]
Increase (Decrease) in Temporary Equity [Roll Forward]
Accretion adjustments of redeemable noncontrolling interest to redemption value	$ 3,281,000
Net income / (loss) attributable to common stockholders	(1,084,000)
Ending balance at Dec. 31, 2021	12,888,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued in connection with equity based plans (in shares)				776,000
Common stock issued in connection with equity-based plans	$ 5,704,000			$ 8,000	5,696,000
Purchases of treasury stock (in shares)	0
Purchases of treasury stock	$ 0
Tax withholdings related to vesting of restricted stock units	(4,476,000)				(4,476,000)
Stock-based compensation expense	38,694,000				38,694,000
Equity component of convertible senior notes, net	56,515,000				56,515,000
Accretion adjustments of redeemable noncontrolling interest to redemption value	(3,281,000)				(3,281,000)
Net income / (loss) attributable to common stockholders	$ 52,259,000							52,259,000
Balance (in shares) at Dec. 31, 2021	0		0
Balance at Dec. 31, 2021	$ 613,167,000	$ (46,543,000)	$ 0	$ 504,000	498,979,000	$ (56,515,000)	$ (5,149,000)	118,833,000	$ 9,972,000
Balance (in shares) at Dec. 31, 2021	50,259,453			50,407,000
Balance (in shares) at Dec. 31, 2021	147,153						147,000
Accounting Standards Update [Extensible List]	Accounting Standards Update 2020-06 [Member]
Increase (Decrease) in Temporary Equity [Roll Forward]
Noncontrolling interest assumed through acquisition	$ 6,770,000
Accretion adjustments of redeemable noncontrolling interest to redemption value	5,037,000
Net income / (loss) attributable to common stockholders	(707,000)
Ending balance at Dec. 31, 2022	23,988,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued in connection with equity based plans (in shares)				578,000
Common stock issued in connection with equity-based plans	$ 4,020,000			$ 6,000	4,014,000
Purchases of treasury stock (in shares)	1,385,592						1,386,000
Purchases of treasury stock	$ (78,844,000)						$ (78,844,000)
Stock-based compensation expense	52,654,000				52,654,000
Reclassification of subsidiary long-term incentive plan liability related to modification	3,104,000				3,104,000
Accretion adjustments of redeemable noncontrolling interest to redemption value	(5,037,000)				(5,037,000)
Net income / (loss) attributable to common stockholders	$ 56,338,000							56,338,000
Balance (in shares) at Dec. 31, 2022	0		0
Balance at Dec. 31, 2022	$ 598,859,000		$ 0	$ 510,000	$ 497,199,000		$ (83,993,000)	$ 185,143,000
Balance (in shares) at Dec. 31, 2022	49,452,709			50,985,000
Balance (in shares) at Dec. 31, 2022	1,532,745						1,533,000